Beyond Today: An Expert View of the Future of Myelofibrosis Treatment


Should you ask your doctor about participation in clinical trials?  Dr. Olatoyosi Odenike, MPN expert and clinical researcher at the University of Chicago Medical Center, says she “absolutely encourages” participating in clinical trials.  With study and understanding of myelofibrosis gaining much ground in the past decade, Dr. Odenike reports that new therapies are in the pipeline, including treatments that combat resistance to JAK inhibitor agents.  “It is always reasonable to ask,” Dr. Odenike states, “would a clinical trial be applicable and relevant?” 

Sign in or Register to view comments.